Size effects of polystyrene nanoparticles on atopic dermatitis-like skin lesions in NC/NGA mice

International Journal of Immunopathology and Pharmacology

Volumn 23, Issue 1, 2010, Pages 131-141

  Yanagisawa, R ^a   Takano, H ^a   Inoue, K I ^a   Koike, E ^a   Sadakane, K ^b   Ichinose, T ^b  

^a NATIONAL INSTITUTE FOR ENVIRONMENTAL STUDIES   (Japan)

^b OITA UNIVERSITY OF NURSING AND HEALTH SCIENCES   (Japan)

Author keywords

Atopic dermatitis; Chemokine; Cytokine; Eosinophils; Mast cells; Polystyrene

Indexed keywords

ALLERGEN; CARBON TETRACHLORIDE; GAMMA INTERFERON; IMMUNOGLOBULIN; INTERLEUKIN 4; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; NANOPARTICLE; POLYSTYRENE;

ADD ON THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOPIC DERMATITIS; CONTROLLED STUDY; HISTOPATHOLOGY; IMMUNE RESPONSE; MALE; MITE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SKIN DEFECT; SYMPTOMATOLOGY; TH2 CELL;

EID: 77951739072     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201002300112     Document Type: Article

References (40)

1. Neame RL, Berth-Jones J, Kurinczuk JJ, Graham-Brown RA. Prevalence of atopic dermatitis in Leicester: a study of methodology and examination of possible ethnic variation. Br J Dermatol 1995; 132:772-777
2. Yura A, Shimizu T. Trends in the prevalence of atopic dermatitis in schoolchildren: longitudinal study in Osaka Prefecture, Japan, from 1985 to 1997. Br J Dermatol 2001; 145:966-973
3. Burney PG, Chinn S, Rona RJ. Has the prevalence of asthma increased in children? Evidence from the national study of health and growth 1973-1986. BMJ 1990; 300:1306-1310
4. Peat JK, Li J. Reversing the trend: reducing the prevalence of asthma. J Allergy Clin Immunol 1999; 103:1-10. (Pubitemid 29063183)
5. Takano H, Yanagisawa R, Inoue K, Ichinose T, Sadakane K, Yoshikawa T. Di-(2-ethylhexyl) phthalate enhances atopic dermatitis-like skin lesions in mice. Environ Health Perspect 2006; 114:1266-1269 (Pubitemid 44184688)
6. Yanagisawa R, Takano H, Inoue K, Koike E, Sadakane K, Ichinose T. Effects of maternal exposure to di-(2-ethylhexyl) phthalate during fetal and/or neonatal periods on atopic dermatitis in male offspring. Environ Health Perspect 2008; 116:1136-41.
7. Borm PJ, Robbins D, Haubold S, et al. The potential risks of nanomaterials: a review carried out for ECETOC. Part Fibre Toxicol 2006; 3:11. (Pubitemid 44530044)
8. Gwinn MR, Vallyathan V. Nanoparticles: health effects-pros and cons. Environ Health Perspect 2006; 114:1818-1825
9. Alessandrini F, Schulz H, Takenaka S, Lentner B, Karg E, Behrendt H, Jakob T. Effects of ultrafine carbon particle inhalation on allergic inflammation of the lung. J Allergy Clin Immunol 2006; 117:824-30. (Pubitemid 44920001)
10. de Haar C, Hassing I, Bol M, Bleumink R, Pieters R. Ultrafine but not fine particulate matter causes airway inflammation and allergic airway sensitization to co-administered antigen in mice. Clin Exp Allergy 2006; 36:1469-1479 (Pubitemid 44674132)
11. Inoue K, Takano H, Yanagisawa R, Sakurai M, Ichinose T, Sadakane K, Yoshikawa T. Effects of nano particles on antigen-related airway inflammation in mice. Respir Res 2005; 6:106. (Pubitemid 41410133)
12. Inoue KI, Koike E, Yanagisawa R, Hirano S, Nishikawa M, Takano H. Effects of multi-walled carbon nanotubes on a murine allergic airway inflammation model. Toxicol Appl Pharmacol 2009; 237:306-316
13. Yanagisawa R, Takano H, Inoue K, Koike E, Kamachi T, Sadakane K, Ichinose T. Titanium dioxide nanoparticles aggravate atopic dermatitis-like skin lesions in NC/Nga mice. Exp Biol Med (Maywood) 2009; 234:314-322
14. Oberdorster G, Ferin J, Lehnert BE. Correlation between particle size, in vivo particle persistence, and lung injury. Environ Health Perspect 1994; 102(S)5:173-179
15. Yamamoto A, Honma R, Sumita M, Hanawa T. Cytotoxicity evaluation of ceramic particles of different sizes and shapes. J Biomed Mater Res A 2004; 68:244-256 (Pubitemid 38524718)
16. Brown DM, Wilson MR, MacNee W, Stone V, Donaldson K. Size-dependent proinflammatory effects of ultrafine polystyrene particles: a role for surface area and oxidative stress in the enhanced activity of ultrafines. Toxicol Appl Pharmacol 2001; 175:191-199
17. Dailey LA, Jekel N, Fink L, Gessler T, Schmehl T, Wittmar M, Kissel T, Seeger W. Investigation of the proinflammatory potential of biodegradable nanoparticle drug delivery systems in the lung. Toxicol Appl Pharmacol 2006; 215:100-108
18. Inoue K, Takano H, Yanagisawa R, Koike E, Shimada A. Size effects of latex nanomaterials on lung inflammation in mice. Toxicol Appl Pharmacol 2009; 234:68-76.
19. Granum B, Gaarder PI, Eikeset A, Stensby BA, Lovik M. The adjuvant effect of particles-importance of genetic background and pre-sensitisation. Int Arch Allergy Immunol 2000; 122:167-173
20. Nygaard UC, Ormstad H, Aase A, Lovik M. The IgE adjuvant effect of particles: characterisation of the primary cellular response in the draining lymph node. Toxicology 2005; 206:181-193 (Pubitemid 39601031)
21. Nygaard UC, Samuelsen M, Aase A, Lovik M. The capacity of particles to increase allergic sensitization is predicted by particle number and surface area, not by particle mass. Toxicol Sci 2004; 82:515-524
22. Edwards EK Jr., Edwards EK Sr. Unusual cutaneous reaction to polystyrene in an otherwise healthy population. Contact Dermatitis 1998; 38:50.
23. Takano H, Yoshikawa T, Ichinose T, Miyabara Y, Imaoka K, Sagai M. Diesel exhaust particles enhance antigen-induced airway inflammation and local cytokine expression in mice. Am J Respir Crit Care Med 1997; 156:36-42.
24. Sadakane K, Takano H, Ichinose T, Yanagisawa R, Shibamoto T. Formaldehyde enhances mite allergen-induced eosinophilic inflammation in the murine airway. J Environ Pathol Toxicol Oncol 2002; 21:267-276. (Pubitemid 35257754)
25. Moghimi SM, Hunter AC, Murray JC. Nanomedicine: current status and future prospects. Faseb J 2005; 19:311-330.
26. Larina IV, Evers BM, Ashitkov TV, Bartels C, Larin KV, Esenaliev RO. Enhancement of drug delivery in tumors by using interaction of nanoparticles with ultrasound radiation. Technol Cancer Res Treat 2005; 4:217-226.
27. Denda M, Sato J, Tsuchiya T, Elias PM, Feingold KR. Low humidity stimulates epidermal DNA synthesis and amplifies the hyperproliferative response to barrier disruption: implication for seasonal exacerbations of inflammatory dermatoses. J Invest Dermatol 1998; 111:873-878
28. Tabata N, Tagami H, Kligman AM. A twenty-four-hour occlusive exposure to 1% sodium lauryl sulfate induces a unique histopathologic inflammatory response in the xerotic skin of atopic dermatitis patients. Acta Derm Venereol 1998; 78:244-247
29. Pflucker F, Hohenberg H, Holzle E, Will T, Pfeiffer S, Wepf R, Diembeck W, Wenck H, Gers-Barlag H. The outermost stratum corneum layer is an effective barrier against dermal uptake of topically applied micronized titanium dioxide. Int J Cosmet Sci 1999; 21:399-411.
30. Schulz J, Hohenberg H, Pflucker F, et al. Distribution of sunscreens on skin. Adv Drug Deliv Rev 2002; 54(S)1:157-163.
31. Kiss B, Biro T, Czifra G, et al. Investigation of micronized titanium dioxide penetration in human skin xenografts and its effect on cellular functions of human skin-derived cells. Exp Dermatol 2008; 17:659-667
32. Mahe B, Vogt A, Liard C, et al. Nanoparticle-based targeting of vaccine compounds to skin antigen-presenting cells by hair follicles and their transport in mice. J Invest Dermatol 2009; 129:1156-1164
33. Kay AB, Ying S, Varney V, Gaga M, Durham SR, Moqbel R, Wardlaw AJ, Hamid Q. Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5, and granulocyte/macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects. J Exp Med 1991; 173:775-778
34. Rousset F, Robert J, Andary M, Bonnin JP, Souillet G, Chretien I, Briere F, Pene J, de Vries JE. Shifts in interleukin-4 and interferon-gamma production by T cells of patients with elevated serum IgE levels and the modulatory effects of these lymphokines on spontaneous IgE synthesis. J Allergy Clin Immunol 1991; 87:58-69.
35. Lester MR, Hofer MF, Gately M, Trumble A, Leung DY. Down-regulating effects of IL-4 and IL-10 on the IFN-gamma response in atopic dermatitis. J Immunol 1995; 154:6174-6181
36. Homey B, Meller S, Savinko T, Alenius H, Lauerma A. Modulation of chemokines by staphylococcal superantigen in atopic dermatitis. Chem Immunol Allergy 2007; 93:181-194
37. Kaburagi Y, Shimada Y, Nagaoka T, Hasegawa M, Takehara K, Sato S. Enhanced production of CC-chemokines (RANTES, MCP-1, MIP-1alpha, MIP-1beta, and eotaxin) in patients with atopic dermatitis. Arch Dermatol Res 2001; 293:350-355
38. Nakajima T, Inagaki N, Tanaka H, et al. Marked increase in CC chemokine gene expression in both human and mouse mast cell transcriptomes following Fcepsilon receptor I cross-linking: an interspecies comparison. Blood 2002; 100:3861-3868
39. Wakahara S, Fujii Y, Nakao T, Tsuritani K, Hara T, Saito H, Ra C. Gene expression profiles for Fc epsilon RI, cytokines and chemokines upon Fc epsilon RI activation in human cultured mast cells derived from peripheral blood. Cytokine 2001; 16:143-152
40. Yamamoto M, Haruna T, Imura K, Hikita I, Furue Y, Higashino K, Gahara Y, Deguchi M, Yasui K, Arimura A. Inhibitory effect of a potent and selective cytosolic phospholipase A2alpha inhibitor RSC-3388 on skin inflammation in mice. Pharmacology 2008; 81:301-311